tiprankstipranks
JBT Marel (JBTM)
NYSE:JBTM
US Market
Want to see JBTM full AI Analyst Report?

JBT Marel (JBTM) Earnings Dates, Call Summary & Reports

258 Followers

Earnings Data

Report Date
Jul 29, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
2.02
Last Year’s EPS
1.49
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 04, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong commercial momentum, margin expansion and cash generation led by robust poultry demand and successful integration synergies, supported by clear multi-year targets under the NextGen strategy. Key near-term weaknesses centered on Prepared Food & Beverage, notably warehouse automation underperformance and tariff-related cost pressure. Management maintained full-year guidance and expects sequential recovery in weaker areas, with continued deleveraging and strong order intake underpinning confidence.
Company Guidance
JBT Marel is reaffirming its full‑year 2026 guidance after a strong Q1 (revenue $936M, +10% YoY; organic +4%, FX +6%; adjusted EBITDA $142M, margin 15.2% up 210 bps; free cash flow $100M, FCF conversion 70%; orders >$1B, +17% YoY), with full‑year revenue growth at the midpoint of 6%, expected adjusted EBITDA margin expansion of 145 bps at the midpoint, and adjusted EPS improvement of 29% at the midpoint; Q2 revenue is guided to $975M–$1.0B with an adjusted EBITDA margin of 17.0%–17.5%; balance‑sheet and cash targets include reducing leverage from 2.6x at Q1 to ~2.0x by year‑end, and tariff assumptions leave a 25–50 bps headwind to full‑year results (no IEEPA refunds assumed); longer‑term NextGen targets call for 2026–2028 organic revenue CAGR of 5–7% and a 20% adjusted EBITDA margin in 2028.
Strong Order Momentum
Orders exceeded $1 billion for the second consecutive quarter, a year-over-year increase of 17%, with double-digit order growth across both Protein Solutions and Prepared Food & Beverage segments and broad-based geographic strength (sequential increases in Europe, North America and Latin America).
Consolidated Revenue Growth
First quarter consolidated revenue of $936 million, up approximately 10% year-over-year (organic growth 4% and foreign exchange contributing ~6%).
Significant EBITDA and Margin Expansion
Consolidated adjusted EBITDA of $142 million, up 27% year-over-year; adjusted EBITDA margin improved to 15.2%, a 210 basis point increase versus prior year.
Protein Solutions Outperformance
Protein Solutions revenue of $460 million, up 22% year-over-year (including ~8% FX benefit); organic growth driven by higher poultry volume. Segment adjusted EBITDA margin improved by more than 500 basis points to 21.7%, driven by poultry volume leverage, synergies and continuous improvement.
Strong Free Cash Flow and Conversion
Generated free cash flow of $100 million in Q1, driven by earnings and increased customer advance payments; free cash flow conversion to adjusted EBITDA was 70%.
Progress on Deleveraging
Leverage ratio improved to 2.6x at the end of Q1, with the company remaining on track to reduce leverage to approximately 2.0x by year-end.
Affirmed Full-Year Guidance
Management maintained full-year 2026 guidance: at the midpoint, implies revenue growth of ~6%, adjusted EBITDA margin expansion of ~145 basis points, and adjusted EPS improvement of 29%.
Near-Term Outlook
Second-quarter revenue guidance of $975 million to $1.0 billion and adjusted EBITDA margin guidance of 17.0% to 17.5%.
NextGen Strategy and 2028 Targets
Investor Day unveiled NextGen strategy and 2028 targets: 3-year organic revenue CAGR of 5%–7% and a target adjusted EBITDA margin of 20% by 2028, supported by cross-selling, product and digital enhancements, customer-centric service, continuous improvement and disciplined M&A.
Synergy Realization and Commercial Integration
Management cited meaningful year-over-year margin expansion enabled by synergy savings and successful integration of JBT and Marel, along with cross-selling synergies driving orders and backlog.

JBT Marel (JBTM) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

JBTM Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 29, 2026
2026 (Q2)
2.02 / -
1.49
May 04, 2026
2026 (Q1)
1.48 / 1.58
0.9762.89% (+0.61)
Feb 23, 2026
2025 (Q4)
1.90 / 1.98
1.716.47% (+0.28)
Nov 03, 2025
2025 (Q3)
1.50 / 1.94
1.529.33% (+0.44)
Aug 04, 2025
2025 (Q2)
1.28 / 1.49
1.0541.90% (+0.44)
May 05, 2025
2025 (Q1)
0.84 / 0.97
0.8514.12% (+0.12)
Feb 24, 2025
2024 (Q4)
1.81 / 1.70
1.421.43% (+0.30)
Oct 22, 2024
2024 (Q3)
1.41 / 1.50
1.1135.14% (+0.39)
Jul 30, 2024
2024 (Q2)
1.24 / 1.05
0.978.25% (+0.08)
May 01, 2024
2024 (Q1)
0.84 / 0.85
0.94-9.57% (-0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

JBTM Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 04, 2026
$116.44
Feb 23, 2026
$163.29$163.75+0.28%
Nov 03, 2025
$124.45$138.23+11.07%
Aug 04, 2025
$133.35$139.47+4.59%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does JBT Marel (JBTM) report earnings?
JBT Marel (JBTM) is schdueled to report earning on Jul 29, 2026, After Close (Confirmed).
    What is JBT Marel (JBTM) earnings time?
    JBT Marel (JBTM) earnings time is at Jul 29, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is JBTM EPS forecast?
          JBTM EPS forecast for the fiscal quarter 2026 (Q2) is 2.02.